Headlands Technologies LLC Has $2.16 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Headlands Technologies LLC increased its shareholding in Option Care Health, Inc. by 299.9%, owning 61,834 shares valued at approximately $2.16 million.
• Institutional investors collectively hold 98.05% of Option Care Health's stock, indicating strong institutional confidence in the company.
• Analysts have a consensus rating of "Moderate Buy" for Option Care Health, with target prices ranging from $35.75 to $40.00, reflecting positive growth expectations.

Headlands Technologies LLC lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 299.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,834 shares of the company's stock after buying an additional 46,371 shares during the period. Headlands Technologies LLC's holdings in Option Care Health were worth $2,161,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of OPCH. Quadrant Capital Group LLC boosted its position in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares during the period. Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Option Care Health during the fourth quarter worth about $47,000. Bessemer Group Inc. raised its holdings in Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after acquiring an additional 599 shares in the last quarter. Finally, Wealthquest Corp bought a new stake in Option Care Health during the first quarter worth about $66,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on OPCH. Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Price Performance

Option Care Health stock opened at $27.91 on Thursday. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The stock's 50 day moving average is $30.82 and its 200-day moving average is $31.94. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $4.53 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 1.78 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The firm's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.30 earnings per share. Equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.